Vestal Point Capital, LP Sutro Biopharma, Inc. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,600,000 shares of STRO stock, worth $2.37 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,600,000
Previous 2,570,000
1.17%
Holding current value
$2.37 Million
Previous $4.73 Billion
64.23%
% of portfolio
0.12%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
119Shares Held
59.2MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.79 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$6.29 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.95 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$4.04 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$4 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $47.5M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...